CXCL9 Protein

Produktnummer ABIN935628

Dieses Recombinant CXCL9-Protein wird in Escherichia coli (E. coli) exprimiert.

Kurzübersicht für CXCL9 Protein (ABIN935628)

Target: CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))

Protein-Typ: Recombinant

Biologische Aktivität: Active

Spezies: Human

Quelle: Escherichia coli (E. coli)

Reinheit: > 98 % pure

Produktdetails

Sequenz: TPVVRKGRCS CISTNQGTIH LQSLKDLKQF APSPSCEKIE IIATLKNGVQ TCLNPDSADV KELIKKWEKQ VSQKKKQKNG KKHQKKKVLK VRKSQRSRQK KTT

Produktmerkmale: Purified recombinant Human MIG protein
Expression System: E.coli
Bioactivity: Determined by its ability to chemoattract human peripheral blood T lymphoytes using a concentration range of 10.0-100.0 ng/mL.

Endotoxin-Niveau: < 0.1 ng per µg (1 EU/µg).

Anwendungsinformationen

Applikationshinweise: Each Investigator should determine their own optimal working dilution for specific applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Reconstitute in water to a concentration of 0.1-1.0 mg/mL. The solution canthen be diluted into other aqueous buffers.

Buffer: Supplied lyophilized with no additives.

Konservierungsmittel: Without preservative

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: RT/-20 °C

Antigendetails

Target: CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))

Andere Bezeichnung: MIG

Hintergrund: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on Mouse cells.
Alternative Names: CXCL9 protein, Monokine Induced by Interferon-gamma protein

Molekulargewicht: 11.7 kDa